256 related articles for article (PubMed ID: 18827905)
1. Early vascular aging (EVA): consequences and prevention.
Nilsson PM
Vasc Health Risk Manag; 2008; 4(3):547-52. PubMed ID: 18827905
[TBL] [Abstract][Full Text] [Related]
2. The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome.
Nilsson PM; Lurbe E; Laurent S
J Hypertens; 2008 Jun; 26(6):1049-57. PubMed ID: 18475139
[TBL] [Abstract][Full Text] [Related]
3. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
Scheen AJ
Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
[TBL] [Abstract][Full Text] [Related]
4. Early Vascular Aging in Hypertension.
Nilsson PM
Front Cardiovasc Med; 2020; 7():6. PubMed ID: 32118044
[TBL] [Abstract][Full Text] [Related]
5. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
6. Potential Role of Endothelin in Early Vascular Aging.
Trindade M; Oigman W; Fritsch Neves M
Curr Hypertens Rev; 2017; 13(1):33-40. PubMed ID: 28413991
[TBL] [Abstract][Full Text] [Related]
7. Prevention of cardiovascular events in elderly people.
Andrawes WF; Bussy C; Belmin J
Drugs Aging; 2005; 22(10):859-76. PubMed ID: 16245959
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hypertension in patients with diabetes.
Sowers JR
Arch Intern Med; 2004 Sep; 164(17):1850-7. PubMed ID: 15451759
[TBL] [Abstract][Full Text] [Related]
9. [Biological aging and apoptosis--mechanism in cardiovascular disease?].
Nilsson P
Nord Med; 1998 Mar; 113(3):82-4. PubMed ID: 9528285
[TBL] [Abstract][Full Text] [Related]
10. Impact of biological aging on arterial aging in American Indians: findings from the Strong Heart Family Study.
Peng H; Zhu Y; Yeh F; Cole SA; Best LG; Lin J; Blackburn E; Devereux RB; Roman MJ; Lee ET; Howard BV; Zhao J
Aging (Albany NY); 2016 Aug; 8(8):1583-92. PubMed ID: 27540694
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
[TBL] [Abstract][Full Text] [Related]
12. Vascular Aging: Lessons From Pediatric Hypertension.
Litwin M; Feber J; Ruzicka M
Can J Cardiol; 2016 May; 32(5):642-9. PubMed ID: 27040097
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of hypertension in type 2 diabetes mellitus--2002 update].
Teuscher AU; Diem P
Ther Umsch; 2002 Aug; 59(8):422-8. PubMed ID: 12235735
[TBL] [Abstract][Full Text] [Related]
14. Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Fyhrquist F; Silventoinen K; Saijonmaa O; Kontula K; Devereux RB; de Faire U; Os I; Dahlöf B
J Hum Hypertens; 2011 Dec; 25(12):711-8. PubMed ID: 21697896
[TBL] [Abstract][Full Text] [Related]
15. [From cardiovascular prevention to anti-aging medicine: influence on telomere and cell aging].
Gleichmann U; Gleichmann US; Gleichmann S
Dtsch Med Wochenschr; 2011 Sep; 136(38):1913-6. PubMed ID: 21915807
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
